There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of ...

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT ...